Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LadRx Corp LADX

Healthcare Biotechnology
LadRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company focuses on the discovery, research and clinical development of anti-cancer drug candidates that employ technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The Company’s linker activated drug release (LADR) technology platform consists of an... see more

Recent & Breaking News (OTCQB:LADX)

CytRx Reports 2014 First Quarter Financial Results

Business Wire May 1, 2014

CytRx to Present Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data in Second-Line Soft Tissue Sarcoma at Upcoming Research and Development Day

Business Wire April 28, 2014

EQUITY ALERT: Rosen Law Firm Reminds CytRx Corporation Investors of Important May 14, 2014 Deadline in the Class Action Filed by the Firm -- CYTR

GlobeNewswire April 26, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in CytRx Corporation of Class Action Lawsuit and Upcoming Deadline -- CYTR

GlobeNewswire April 25, 2014

CytRx Announces Global Phase 2b Trial of Aldoxorubicin in Soft Tissue Sarcomas Selected for Oral Presentation at the 2014 ASCO Annual Meeting

Business Wire April 24, 2014

Hagens Berman: 21 Days Remain Until May 13, 2014 Lead Plaintiff Deadline in CytRx Securities Fraud Class Action

PR Newswire April 23, 2014

Lieff Cabraser Reminds CytRx Corporation Investors of Upcoming Deadline in Class Action Litigation - CYTR

Business Wire April 23, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline

Business Wire April 15, 2014

Who’s suing who? GM (GM) trims ranks and Growlife (PHOT) loses friends

Gaalen Engen April 15, 2014

Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors of the May 13, 2014 Deadline to File for Lead Plaintiff in the Securities Fraud Class Action Against CytRx Corporation -- CYTR

GlobeNewswire April 15, 2014

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR

PR Newswire April 11, 2014

Who’s suing who? GM (GM), Growlife (PHOT) targeted while Barker Minerals (V.BML) lawyers up

Gaalen Engen April 10, 2014

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against CytRx Corporation

Business Wire April 10, 2014

CytRx Announces Research and Development Day and Webcast

Business Wire April 10, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CytRx Corporation and Certain Officers -- CYTR

GlobeNewswire April 9, 2014

Hagens Berman Reminds CytRx Investors of May 13, 2014 Lead Plaintiff Deadline and Inclusion of Those Who Purchased Stock from Feb. 5, 2014 Offering

Business Wire April 9, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR

GlobeNewswire April 8, 2014

Technical Update on Active Stocks -- Research on CytRx, FireEye, Yandex, and Hewlett-Packard

PR Newswire April 4, 2014

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR

GlobeNewswire April 4, 2014

The Shuman Law Firm Investigates CytRx Corporation

Business Wire April 3, 2014